PainReform Ltd banner

PainReform Ltd
NASDAQ:PRFX

Watchlist Manager
PainReform Ltd Logo
PainReform Ltd
NASDAQ:PRFX
Watchlist
Price: 2.22 USD 0.91% Market Closed
Market Cap: $1.7m

PainReform Ltd
Investor Relations

PainReform Ltd. operates as a pharmaceutical company. The Company’s main activity is to develop reformulation of established pain therapeutics. PainReform Ltd provides technology, which is dedicated to prolong and enhance efficacy, minimize adverse effects and increase patients convenience as well as faster return of motor function.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Dr. Ehud Geller Ph.D.
Executive Chairman
No Bio Available
Mr. Ilan Hadar M.B.A.
CEO & CFO
No Bio Available
Dr. Sigal Aviel
Chief Operating Officer
No Bio Available
Prof. Eli Hazum Ph.D.
CTO & Director
No Bio Available
Ms. Rita Keynan
Vice President of Pharmaceutical Operations
No Bio Available
Dr. Stephen A. Cooper D.M.D Ph.D.
Executive Vice President of Development
No Bio Available

Contacts

Address
TEL AVIV-YAFO
65 Yigal Alon St.
Contacts
+97237177051.0
www.painreform.com
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett